Groesser, Leopold and Peterhof, Eva and Evert, Matthias and Landthaler, Michael and Berneburg, Mark and Hafner, Christian (2016) BRAF and RAS Mutations in Sporadic and Secondary Pyogenic Granuloma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 136 (2). pp. 481-486. ISSN 0022-202X, 1523-1747
Full text not available from this repository. (Request a copy)Abstract
Pyogenic granuloma (PG) is a common benign vascular skin lesion presenting as a rapidly growing angiomatous papule. The pathogenesis of most sporadic PGs and PGs associated with port wine stains (PWSs) remains elusive. We report that of 10 PGs secondarily arisen on a PWS, 8 showed a BRAF c.1799T>A (p.(Val600Glu)) and 1 a NRAS c.182A>G (p.(Gln61Arg)) mutation. The GNAQ c.548G>A mutation was identified in the PG and in the respective underlying PWS, indicating that PGs originate from cells of the PWS. In contrast to PG, 12 papulonodular lesions, which had developed in the PWSs of seven patients, showed a RAS and BRAF wild-type status. In sporadic PG we identified the BRAF c.1799T>A mutation in 3 of 25, a BRAF c.1391G>A mutation in 1 of 25, and a KRAS c.37G>C mutation in 1 of 25. Mutation-specific immunohistochemical detection of BRAF p.(Val600Glu) confirmed endothelial cells as carriers of the mutation in secondary and sporadic PG. Our study identifies the BRAF c.1799T>A mutation as a major driver mutation in the pathogenesis of, particularly, secondary PG. These data shed light on the hitherto undetermined genetic basis of PG and classify PG as a benign neoplasm.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | VASCULAR MALFORMATIONS; MELANOMA; ANGIOGENESIS; CANCER; TUMORS; CELLS; KRAS; |
Subjects: | 600 Technology > 610 Medical sciences Medicine |
Divisions: | Medicine > Lehrstuhl für Dermatologie und Venerologie Medicine > Lehrstuhl für Pathologie |
Depositing User: | Dr. Gernot Deinzer |
Date Deposited: | 12 Mar 2019 12:55 |
Last Modified: | 12 Mar 2019 12:55 |
URI: | https://pred.uni-regensburg.de/id/eprint/2422 |
Actions (login required)
![]() |
View Item |